Autoantibodies from bullous pemphigoid (BP) patients define a 230-kD protein found in the basement membrane of stratified squamous epithelia. The purpose of this study was to isolate and characterize a cDNA clone with coding sequences for BP antigen. Poly(A+) RNA derived from total RNA of cultured keratinocytes was used, with oligo-dT priming, to construct a cDNA library in the Xgtl1 expression vector, which was screened by the immunoperoxidase method with one BP serum. One darkly stained clone, called here the BP clone, was further characterized. 9 of 9 BP sera, but none of 6 normal and 11 pemphigus sera, bound the plaques of this BP clone. Furthermore, BP IgG affinity purified on plaques of this clone, but not unrelated clones, bound the epidermal basement membrane by immunofluorescence and immunoprecipitated the 230-kD BP antigen from extracts of cultured keratinocytes. Eco RI digestion of the BP clone's cDNA insert demonstrated a 680-and 1,500-bp fragment. Northern blots of total keratinocyte RNA showed that complementary riboprobes transcribed from both fragments hybridized to a 9-kb RNA. Dideoxy DNA sequencing from the 5' end of the BP cDNA demonstrated a 1,992-bp open reading frame, encoding a peptide of 76 kD. This BP cDNA clone will be valuable for understanding the protein structure, expression, and gene organization of BP antigen.
Introduction
Bullous pemphigoid (BP)' is an autoimmune blistering disease in which autoantibodies bind the epidermal basement membrane zone (BMZ) and, probably as a result of this binding, subepidermal blisters develop (1, 2) . These autoantibodies are found in the BMZ of the patients' skin and in their sera. By indirect immunofluorescence these BP autoantibodies bind the BMZ of normal stratified squamous epithelia, not only in human tissue but in the tissue of most vertebrates (3) . Thus, these autoantibodies define a molecule found in the normal BMZ of stratified squamous epithelia, such as skin and mucous membranes.
Recent immunoelectron microscopic studies have demonstrated that BP autoantibodies bind to both the extracellular and intracellular parts of the hemidesmosomes of the basal keratinocytes (4) (5) (6) . Because BP antigen is only found associated with basal keratinocytes, it is a useful marker for this relatively undifferentiated basal cell (7) . In addition, basal cells, but not more differentiated keratinocytes, synthesize BP antigen (8) .
With the above data in mind, characterization of BP antigen would be useful in furthering our understanding of several aspects ofskin and mucous membrane biology, such as: (a) the normal BMZ of stratified squamous epithelia; (b) the structure and function of normal hemidesmosomes; (c) the regulation of synthesis of differentiation molecules in the epidermis; and (d) the pathophysiology not only of BP, but also, perhaps, of certain hereditary diseases such as junctional epidermolysis bullosa, in which blisters occur in the BMZ of stratified squamous epithelia and there are abnormalities of the hemidesmosomes (9) .
Thus far characterization of BP antigen has been carried out mostly by immunochemical means. Recent studies have shown that although there may be some heterogeneity of the BP antigen, autoantibodies from almost all patients bind an -230-kD protein as determined either by immunoprecipitation of extracts of cultured keratinocytes or by immunoblotting of extracts of normal human epidermis (10) (11) (12) (13) . For example, in our laboratory sera from 26 of 27 BP patients immunoprecipitate a 230-kD polypeptide from extracts of cultured keratinocytes, whereas none of 59 diseased and normal sera controls bind this molecule (12) . This finding was confirmed by another laboratory (5) . The specificity of these immunochemical studies have established this 230-kD protein as the major BP antigen.
Another useful approach to further characterize BP antigen and to elucidate its amino acid sequence, protein structure, control of its expression, and the organization of its gene would be by molecular biologic techniques. A useful first step in this direction would be the isolation ofa cDNA fragment or probe that contains coding sequences for BP antigen. The purpose of this study was to isolate and characterize such a cDNA clone using sera from BP patients. 10 mM Tris-HCI, pH 7.4, which resulted in precipitation of keratins. The keratin pellet was collected by centrifugation at 100,000 g for 30 min. 1.5 ml ofthe BP serum was absorbed three times with -5 mg (each absorption) of keratin at room temperature for 1 h. Indirect immunofluorescence on monkey esophagus indicated no difference in the anti-BMZ titer ofthe serum before and after absorption.
As specificity controls for the staining of the putative BP fusion protein we used an additional eight BP sera, each of which was known to immunoprecipitate the 230-kD BP antigen, and as negative controls we used sera from seven patients with pemphigus vulgaris, four patients with pemphigus foliaceus, and six normal individuals. These BP and control sera were not preabsorbed with keratin.
Human keratinocyte cell culture. Keratinocytes from neonatal foreskin were cultured on irradiated 3T3 cells as previously reported (15) and used in the first passage. Cells grown under these conditions have been shown to synthesize BP antigen (15).
Construction ofXgtl]l library. In order to find a cDNA clone with coding sequences for BP antigen, we constructed a cDNA expression library in Xgt 1I as originally described by Young and Davis (16) . Total RNA was extracted from each ofeight 150-mm dishes ofjust confluent human keratinocytes with 5 ml of4-M guanidine isothiocyanate, 0.5% sodium lauroyl sarcosine, 0.1 M 2-mercaptoethanol in 25 mM sodium citrate buffer, pH 7. The extracted RNA was pelleted through a 5.7-M CsC12 cushion (17) This mixture was then plated in 7.5 ml top agarose containing 10 mM MgSO4 on 150-mm LB-agar plates (also containing 10 mM MgSO4).
As described (20) , nitrocellulose filters saturated with isopropyl f3-thiogalactopyranoside (IPTG) were incubated on phage plaques overnight to induce synthesis of fusion protein. These nitrocellulose filters were then used for immunoperoxidase staining with serum to localize plaques that produce fusion proteins that bind particular sera (11) . Sera were diluted 1:100 in 3% BSA in 0.15 M NaCl, 0.5% NP-40 in 10 mM Tris-HCI, pH 7.4. The diluted sera were absorbed twice with 1/50 their volume of E. coli lysate (Bio-Rad Laboratories, Richmond, CA).
Affinity purification ofantibodies on Xgtl I plaque protein. To obtain the affinity-purified BP IgG that bound protein produced by the purified BP Xgtl 1 clone, we plated the isolated clone at a density (just short of confluence) of 1,000-4,000 plaques/ I 50-mm plate. Fusion protein synthesis was induced as described above, with IPTG-saturated nitrocellulose filters. These filters were then treated as for immunoperoxidase staining, but after incubation ofthe BP serum (diluted 1:100 in 3% BSA in 0.5 M NaCl, 1% NP-40, 0.5% sodium deoxycholate in 10 mM Tris-HCl, pH 7.4 [WB2]), the filters, in 150-mm culture dishes, were washed five times with WB2 then twice briefly with H20. The bound antibodies were eluted twice with 10 ml ofa 370C solution of 50 mM glycine and 500 mM NaCl, pH 2.3, for 15 min each on a rocking platform. The eluates were immediately neutralized with 1/10 vol of 500 mM Na2PO4. The eluted, neutralized antibodies were dialyzed against PBS at 4°C, then concentrated on a PM-10 filter (Amicon Corp., Danvers, MA) followed by a Centricon 30 (Amicon Corp.) to a final volume of -60-100 ,ul.
Restriction enzyme analysis of the XgtlJ cDNA insert. A liquid lysate of the BP Xgtl 1 clone was prepared in Y1088 cells. Phage DNA was isolated by a rapid lambda DNA extraction technique (21) . In brief, cellular DNA, RNA, and some protein were removed from the lysate with DE52 cellulose (Whatman Laboratory Products, Inc., Hillsboro, OR) in LB broth. The phage protein and excess cellular proteins were then extracted with phenol/chloroform, leaving the phage DNA in the aqueous phase. After repeat extraction with chloroform, and ethanol precipitation, the phage DNA was digested with various restriction enzymes according to the manufacturer's directions (Bethesda Research Laboratories, Gaithersburg, MD). 5% polyacrylamide and 0.8% agarose gels were used to identify digested fragments (18 6 and 8% polyacrylamide-urea gels.
Results
General characteristics of the XgtJJ cDNA library. Poly(A+) RNA isolated from cultured human keratinocytes, known to express the 230-kD BP antigen (10), was used to construct cDNA that was cloned into the Eco RI site of the Xgtl 1 expression vector (16) . The poly(A+) RNA was primed with oligo-dT, thereby biasing the library to the 3' end of the RNA (or to the C-terminal end ofthe corresponding protein). These cloned cDNAs should reflect sequences of the keratinocyte mRNAs, including the BP antigen. To determine the number of independent cDNA recombinants in the library, we titered the unamplified library on X-gal agar plates, on which nonrecombinant phages are blue and recombinant phages are white. The library contained 70% recombinants for a total of 2.7 X I07 independent recombinants. As discussed in Methods, the average insert size was determined to be 1 kb (range 0.5-3.8 kb).
Because cDNAs containing coding sequences for keratins, the major proteins of keratinocytes, should be relatively abundant, we first tested the ability of this library to produce proteins immunoreactive with antibodies to keratin. We used antibodies raised to, and affinity-purified with, the COOH-terminal end of K14 (22 further characterized. To determine whether the protein produced by this putative BP clone specifically bound antibodies in BP sera, we partially purified the clone so that the immunoperoxidase staining of this clone with many different sera could be compared with the background (nonspecific) staining of other clones. Of 9 BP sera, all specifically stained the plaques of this IPTG-induced clone, whereas 6 normal sera and 11 pemphigus disease control sera did not (Fig. 1) . These results suggest that this BP clone encodes a major antigenic site of the BP antigen.
To further confirm that the antibodies binding to the products of this clone were typical BP antibodies in that they were capable of binding to the epidermal BMZ and they could immunoprecipitate the BP antigen, we affinity-purified the IgG that bound the purified BP clone. The BP clone was recloned until it was pure and then incubated with the BP serum. After extensive washing, bound BP IgG was eluted with acid glycine (Fig. 2 A) . This affinity-purified IgG was shown by immunofluorescence to bind the BMZ of epidermis (Fig. 2 B) . In addition, the affinity-purified IgG immunoprecipitated the 230-kD BP antigen extracted from metabolically radiolabeled cultured keratinocytes (Fig. 2 C) . These results confirm that the cDNA insert of the BP Xgt 11 clone contains coding sequences for a major antigenic site of BP antigen.
Eco RI digestion of the Xgtl 1 BP clone revealed a cDNA insert of two fragments of -680 and 1,500 bp, as determined by polyacrylamide and agarose gel electrophoresis.
Northern analysis ofkeratinocyte RNA for BP mRNA. To determine the direction of transcription to make antisense riboprobes and to determine the 5' end (in relation to sense mRNA transcription) of the 680-and 1,500-bp Eco RI fragments, we subcloned them into the pGEM3 vector. Two clones were found in which the 1,500-bp fragment was in opposite orientation (BPl 500A, BPl 500B), as determined by restriction enzyme analysis. 32P-riboprobes from each were made with the T7 promoter. Slot blots on keratinocyte total RNA indicated that the BPl 500B clone produced an antisense (complementary) probe to the BP mRNA (Fig. 3) SP6 promoter produced the complementary probe (Fig. 3) .
Conversely, we could determine from these studies that the 5' ends of the 1,500-and 680-bp fragments were adjacent to the T7 promoter in BP1 500A and BP680, respectively.
The complementary riboprobes were then used to perform Northern analysis on keratinocyte total RNA. The probe made from the 1,500-bp fragment identified -9-kb RNA (Fig. 4 A) .
To confirm that both the 680-and 1,500-bp Eco RI fragments in the Xgtl 1 BP clone came from the same original mRNA (rather than coming from two different mRNAs and being cloned in tandem into the Eco RI cloning site), we performed Northern blotting with probes from both fragments. This experiment demonstrated that both probes hybridized to the 9-kb RNA as expected (Fig. 4 B) . The size of this putative BP mRNA is easily large enough to encode for a 230-kD protein.
Orientation of the BP cDNA in Xgtl . Slot blots, as discussed above, were used to determine the 5' ends, in relation to sense mRNA transcription, of the 1,500-and 680-bp BP cDNA Eco RI fragments. Restriction enzyme analysis with Xba I of these fragments in plasmid vector (pGEM; Promega Biotec, Madison, WI) revealed that there were Xba I sites on the 5' end of the 1,500-bp fragment but no sites in the 680-bp fragment (Fig. 5) . DNA sequencing of both fragments confirmed these findings. An Xba I, Kpn I double digest of the Xgt 1 BP clone revealed that the cDNA insert was oriented so that its direction of transcription (5' end) was opposite to that ofthe lac Z gene (Fig. 5 ). This direction of orientation has been previously reported for cDNAs cloned by antibody screening of Xgtl 1 (23, 24) .
Since, presumably, the peptide encoded for by the cDNA in this orientation is promoted by a late lambda, rather than the lac Z, promoter (23) reading frame (ORF), whereas the other two frames showed multiple stop codons. The deduced amino acid sequence ofthe long ORF is shown in Fig. 6 (23, 24) . In this case the expression of the protein encoded for by the cDNA is presumably from a late phage lambda promoter (23 (25) (26) (27) (28) (29) , has demonstrated that autoantibodies from patients can be used to isolate cDNA clones for the corresponding antigens from Xgt 1 expression libraries. This powerful technique should provide a means for the characterization of these antigens at a protein and genetic level. Thus, in the case of BP antigen, the cDNA probe described in this paper and its sequence should prove useful in isolating a full-length cDNA clone (and the corresponding amino acid sequence for the whole antigen). This will in turn provide valuable information about hemidesmosomes, of which BP antigen is a component (4) (5) (6) . In addition, because a probe for BP antigen is now available, studies on the BP genomic DNA and the genetic regulation of expression of BP antigen in differentiating epidermis are feasible. Since BP antigen is produced by basal cells but not more differentiated keratinocytes (8) , these studies should shed light on control of epidermal differentiation.
Finally, this technique of autoantibody screening of cDNA expression libraries would also be feasible for isolation of cDNA clones for other autoimmune blistering diseases such as pemphigus and epidermolysis bullosa acquisita. The autoantibodies in these diseases, as well as in BP, define molecules that are tissue-specific for stratified squamous epithelia, such as skin and mucous membrane. Like BP antigen, these molecules too are regulated with differentiation of epidermis (8) . The isolation ofthese cDNA probes will undoubtedly provide valuable tools for our understanding of normal and diseased skin and mucous membranes.
